Hepatic histopathology of patients with morbid obesity submitted to gastric bypass

Obesity Surgery

Volumn 15, Issue 5, 2005, Pages 661-669

  Pereira Lima, Maria Luiza Rodrigues ^b   Oliveira Mourão, Samuel Conrado ^b   Costa Diniz, Marco Túlio ^b   Rios Leite, Virginia Hora ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE

Author keywords

Histopathology; Morbid obesity; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

GLYCOGEN;

ADULT; AGED; ARTICLE; BARIATRIC SURGERY; BODY MASS; DYSLIPIDEMIA; FEMALE; HISTOPATHOLOGY; HUMAN; LIFESTYLE; LIVER BIOPSY; LIVER FIBROSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; STEATOSIS; STOMACH BYPASS; SURGICAL PATIENT;

ADULT; AGED; BIOPSY; CHI-SQUARE DISTRIBUTION; DIABETES COMPLICATIONS; FATTY LIVER; FEMALE; GASTRIC BYPASS; HUMANS; LIVER; MALE; OBESITY, MORBID; STATISTICS, NONPARAMETRIC;

EID: 20544439374     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892053923888     Document Type: Article

References (31)

1. Prevalence of overweight and obesity among adults. National Center For Health Statistic, Centers for disease control and prevention. Atlanta. Available at: www.cdc.gov/nchs/products/pubs/pubd/hestats/obese /obse99.htm. Last accessed Aug 29, 2003.
2. Monteiro CA, D'A Benício MH, Conde WL et al. Shifting obesity trends in Brazil. Eur J Clin Nutr 2000; 54: 342-6.
3. Shuldiner AR, Munir KM. Genetics of obesity: more complicated than initially thought. Lipids 2003; 38: 97-101.
4. Sociedad Española Para El Estudio De La Obesidad. Consenso Seedo'2000 para la evaluación del sobrepeso y la obesidad y el establecimiento de critérios de intervención terapêutica. Med Clin (Barc) 2000; 115: 587-97.
5. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979; 67: 811-6.
6. Ludwig J, Viggiano TR, McGill DB et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
7. DiehL AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-62.
8. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989; 20: 594-8.
9. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
10. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
11. Poniachik J, Mancilla C, Contreras J et al. Obesity: risk factor for steatohepatitis and hepatic fibrosis. Rev Med Chil 2002; 130: 731-6.
12. Spaulding L, Trainer T, Janiec D. Prevalence of no-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg 2003; 13: 347-9.
13. Brunt EM, Janney CG, Di Bisceglie AM et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
14. Luyckx FH, Desaive C, Thiry A et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes 1998; 22: 222-6.
15. Andersen T, Christoffersen P, Gluud C. The liver in consecutive patients with morbid obesity: A clinical, morphological, and biochemical study. Int J Obes 1984; 8: 107-15.
16. Silverman JF, O'Brien KF, Long S et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990; 85: 1349-55.
17. Gholam PM, Kotler DP, Flancbaum LJ. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg 2002; 12: 49-51.
18. Del Gaudio A, Boschi L, Del Gaudio GA et al. Liver damage in obese patients. Obes Surg 2002; 12: 802-4.
19. Shalhub S, Parsee A, Gallagher SF et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 2004; 14: 54-9.
20. Brunt EM. Nonalcoholic steatohepatitis definition and pathology. Semin Liver Dis 2001; 21: 3-16.
21. Wolf AM, Busch B, Kuhlmann HW et al. Histological changes in the liver of the morbidly obese patients: correlation with metabolic parameters. Obes Surg 2005; 15: 228-37.
22. Papadia FS, Marinari GM, Camerini G et al. Liver damage in severly obese patients: a clinical-biochemical morphologic study on 1,000 liver biopsies. Obes Surg 2004; 14: 952-8.
23. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-5.
24. Sanyal AJ, Campbell-Sargent C, Mirshahi F et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
25. Marchesini G, Brizi M, Bianchi G et al. Nonalcoholic fatty liver disease. A feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
26. Angulo P, Keach JC, Batts KP et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
27. Dallal RM, Mattar SG, Lord JL et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg 2004; 14: 47-53.
28. Neuschwander-Tetri BA, Cadwell SH; Nonalcoholic Steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19.
29. Pessayre D, Berson A, Fromenty B et al. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57-69.
30. Rao MS, Reddy JK. Peroxisomal β-oxidation and steatohepatitis. Semin Liver Dis 2001; 21: 43-55.
31. Salway JG. Glicogen metabolism. In: Salway JG, ed. Metabolism at a Glance, 4th Edn. London: Blackwell Science 1998: 58-9.